uniQure N.V. Increase (Decrease) in Inventories
uniQure N.V. (QURE) reported Increase (Decrease) in Inventories of -$2.42 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-03-02
- uniQure N.V. increase (decrease) in inventories for the quarter ending 2024-12-31 was -$6.30M.
- uniQure N.V. increase (decrease) in inventories for the quarter ending 2024-09-30 was $1.27M, a 76.66% decline year-over-year.
- uniQure N.V. increase (decrease) in inventories for the quarter ending 2024-06-30 was $4.84M, a 77.04% increase year-over-year.
- uniQure N.V. increase (decrease) in inventories for the quarter ending 2024-03-31 was -$2.24M, a 504.34% decline year-over-year.
- uniQure N.V. increase (decrease) in inventories for fiscal 2024 was -$2.42M, a 135.92% decline from fiscal 2023.
- uniQure N.V. increase (decrease) in inventories for fiscal 2023 was $6.74M, a 2.66% decline from fiscal 2022.
- uniQure N.V. increase (decrease) in inventories for fiscal 2022 was $6.92M.
- uniQure N.V. increase (decrease) in inventories for fiscal 2016 was -$480.00K, a 284.62% decline from fiscal 2015.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$5.03M derived: sum of 2 quarters · filed 2026-03-02 | -$185.00K derived: sum of 3 quarters · filed 2026-03-02 | -$2.42M 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.11M derived: sum of 2 quarters · filed 2025-11-10 | $3.88M 10-Q · filed 2025-11-10 | $1.89M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $4.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.61M 10-Q · filed 2025-07-29 | $616.00K derived: sum of 3 quarters · filed 2026-03-02 | $6.06M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$2.24M 10-Q · filed 2025-05-09 | -$4.23M derived: sum of 2 quarters · filed 2026-03-02 | $1.22M derived: sum of 3 quarters · filed 2026-03-02 | $3.95M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.45M derived: sum of 2 quarters · filed 2026-03-02 | $6.19M derived: sum of 3 quarters · filed 2026-03-02 | $6.74M 10-K · filed 2026-03-02 |
| 2023-09-30 | $5.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $8.18M derived: sum of 2 quarters · filed 2024-11-05 | $8.73M 10-Q · filed 2024-11-05 | $11.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.29M 10-Q · filed 2024-08-01 | $6.14M derived: sum of 3 quarters · filed 2025-02-27 | $7.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $553.00K 10-Q · filed 2024-05-07 | $3.40M derived: sum of 2 quarters · filed 2025-02-27 | $4.53M derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.98M derived: sum of 2 quarters · filed 2025-02-27 | $6.92M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.08M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $2.95M 10-Q · filed 2023-08-01 | |||
| 2016-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$400.00K derived: sum of 2 quarters · filed 2019-02-28 | -$449.00K derived: sum of 3 quarters · filed 2019-02-28 | -$480.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | -$326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$375.00K derived: sum of 2 quarters · filed 2017-11-01 | -$406.00K 10-Q · filed 2017-11-01 | |
| 2016-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$80.00K 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | -$31.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $260.00K 10-K · filed 2018-03-14 | |||
| 2014-12-31 | -$882.00K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |